CDP870
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
- The Cochrane database of systematic reviews
- 2011
BACKGROUND
Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms… (More)
Is this relevant?
Review
2010
Review
2010
- Medical oncology
- 2010
Tumor necrosis factor (TNF)-alpha is implicated in the same time in apoptosis and in cell proliferation. TNF-alpha not only acts… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
- Gastroenterology
- 2005
BACKGROUND & AIMS
To investigate the efficacy and safety of certolizumab pegol (a polyethylene-glycolated Fab' fragment of anti… (More)
Is this relevant?
Review
2005
Review
2005
- Reviews in gastroenterological disorders
- 2005
Crohn's disease is a T helper type 1 response immune disease characterized by increased production of interleukin-12 tumor… (More)
Is this relevant?
2004
2004
- Alimentary pharmacology & therapeutics
- 2004
BACKGROUND
CDP870 is a PEGylated Fab' fragment of a humanized monoclonal antibody that neutralizes tumour necrosis factor-alpha… (More)
Is this relevant?
2004
2003
2003
- American Journal of Gastroenterology
- 2003
SAFETY OF CDP870, A PEGYLATED HUMANIZED ANTI-TNF ANTIBODY FRAGMENT, IN CROHN’S DISEASE Stefan Schreiber, M.D.*, Trevor Winter, M… (More)
Is this relevant?
2003
2003
- American Journal of Gastroenterology
- 2003
SAFETY OF CDP870, A PEGYLATED HUMANIZED ANTI-TNF ANTIBODY FRAGMENT, IN CROHN’S DISEASE Stefan Schreiber, M.D.*, Trevor Winter, M… (More)
Is this relevant?
Review
2003
Review
2003
- Best practice & research. Clinical…
- 2003
Tumour necrosis factor (TNF) plays an important role in mediating the inflammation of inflammatory bowel disease, in particular… (More)
Is this relevant?
2002
2002
- Rheumatology
- 2002
OBJECTIVE
Biological products that neutralize tumour necrosis factor alpha (TNF-alpha) are beneficial in rheumatoid arthritis (RA… (More)
Is this relevant?